Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 4:11 PM ET

Date/Time Source News Release
04/14/2025 07:00 PM EDT GlobeNewswire MediciNova To Participate in D. Boral's Capital Global Conference on May 14, 2025
04/08/2025 07:00 PM EDT GlobeNewswire First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
12/05/2024 06:00 PM EST GlobeNewswire MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND
11/19/2024 09:00 AM EST GlobeNewswire MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders
11/14/2024 06:00 PM EST GlobeNewswire MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver
11/11/2024 06:00 PM EST GlobeNewswire MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
10/23/2024 07:00 PM EDT GlobeNewswire MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)
09/30/2024 09:00 AM EDT GlobeNewswire MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
09/03/2024 07:00 PM EDT GlobeNewswire MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting
08/29/2024 07:00 PM EDT GlobeNewswire MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-166 (ibudilast) for the Post-COVID Condition
Page

Additional News

As of June 11, 2025 • 4:11 PM ET

Date/Time Source News Release
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - MediciNova Inc.
02/20/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, February 20th, 2025
02/20/2025 04:30 AM EST US Earnings Reports Expected earnings - MediciNova Inc.
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - MediciNova Inc.
11/12/2024 03:30 PM EST QM US Market Movers News US Companies Moving the Markets, Evening edition
Tue, Nov 12, 2024 as of 4:00 pm ET
09/04/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Sep 04, 2024 as of 10.00 am ET
08/30/2024 08:11 AM EDT SeekingAlpha MediciNova gains after patent win for long COVID therapy
05/10/2024 05:38 AM EDT US Earnings Reports Expected earnings - MediciNova Inc.
05/07/2024 06:46 AM EDT SeekingAlpha MediciNova anti-inflammatory drug gets issue notification for new patent, shares up
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.